Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent-Reference-Cited by-同舟云学术

Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent

Published:2016-03 Issue: Volume:56 Page:69-76
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Haagensen Emma J.,Thomas Huw D.,Mudd Clare,Tsonou Elpida,Wiggins Ceri M.,Maxwell Ross J.,Moore Jonathan D.,Newell David R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Targeting mitogen-activated protein kinase kinase with the inhibitor PD 0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems;Hennig;Hepatology,2010

2. Potent inhibition of thyroid cancer cells by the MEK inhibitor PD 0325901 and its potentiation by suppression of the PI3K and NF-κB pathways;Liu;Thyroid,2008

3. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity;Maira;Mol Cancer Ther,2008

4. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations;Serra;Cancer Res,2008

5. The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma;Baumann;Exp Cell Res,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying mutant-specific multi-drug combinations using comparative network reconstruction;iScience;2022-08

2. Comprehensive bioinformatic analyses of KRAS mutations and deciphering chromatin modification landscape of Caveolin-1 gene by lipid raft destabilization induced modulation of RAS-MAPK axis in colon cancer;Advances in Cancer Biology - Metastasis;2022-07

3. Literature-based translation from synthetic lethality screening into therapeutics targets: CD82 is a novel target for KRAS mutation in colon cancer;Computational and Structural Biotechnology Journal;2022

4. Cancer models in preclinical research: A chronicle review of advancement in effective cancer research;Animal Models and Experimental Medicine;2021-03-29

5. Identifying mutant-specific multi-drug combinations using Comparative Network Reconstruction;2020-12-18